Fellows

For nearly two decades, CURE has funded the training of pediatric oncology fellows at Emory University School of Medicine. Providing funding to further their education helps ensure that those future oncologists become clinicians and researchers we need in order to eradicate childhood cancer.

Dr. Frank Chien

Dr. Chien obtained his undergraduate degree in computer science at Swarthmore College and his MD at Thomas Jefferson University. He continued his pediatric training at Inova Children’s Hospital prior to joining pediatric hematology/oncology fellowship with CHOA and Emory University. His research prior to fellowship focused on the epidemiological patterns in adolescent and young adult cancers. Throughout his fellowship and beyond, he hopes to advance pediatric and adolescent cancer care by developing novel computational strategies to aid in big-data analysis and research.

“I am grateful to CURE for funding my fellowship training position. This not only allows me to train in pediatric cancer care, but also allows me to focus on applying computational methods to analyze the growing literature of oncologic data. I am optimistic that within the upcoming decades, we will fundamentally revolutionize treatment methods and outcomes in pediatric oncology. I hope that our generation of young physicians will see those changes become reality.”

Dr. Frank Chien

Dr. Chien obtained his undergraduate degree in computer science at Swarthmore College and his MD at Thomas Jefferson University. He continued his pediatric training at Inova Children’s Hospital prior to joining pediatric hematology/oncology fellowship with CHOA and Emory University. His research prior to fellowship focused on the epidemiological patterns in adolescent and young adult cancers. Throughout his fellowship and beyond, he hopes to advance pediatric and adolescent cancer care by developing novel computational strategies to aid in big-data analysis and research.

“I am grateful to CURE for funding my fellowship training position. This not only allows me to train in pediatric cancer care, but also allows me to focus on applying computational methods to analyze the growing literature of oncologic data. I am optimistic that within the upcoming decades, we will fundamentally revolutionize treatment methods and outcomes in pediatric oncology. I hope that our generation of young physicians will see those changes become reality.”

Dr. Juhi Jain

Sam Robb Fellow

Dr. Jain received her MD at the University of Miami School of Medicine and completed her residency in pediatrics at Texas Children’s Hospital/Baylor. Dr. Jain’s research will focus on drug screening and formulation focusing on synergy between MERTK and BCL2 inhibitors as well as in combination with conventional chemotherapy and other immunotherapies to optimize therapeutic potential in AML cell lines.

“I am honored and grateful to be supported by CURE Childhood Cancer and the Sam Robb Fund. I am inspired by their mission to conquer childhood cancer and to support patients and their families. As a physician I witness every day the impact CURE has on my patients and their families and I hope, through my research supported by CURE, to further gain knowledge about how different types of cancer respond to treatment and contribute to developing targeted therapies for childhood cancer.”

Dr. Juhi Jain

Sam Robb Fellow

Dr. Jain received her MD at the University of Miami School of Medicine and completed her residency in pediatrics at Texas Children’s Hospital/Baylor. Dr. Jain’s research will focus on drug screening and formulation focusing on synergy between MERTK and BCL2 inhibitors as well as in combination with conventional chemotherapy and other immunotherapies to optimize therapeutic potential in AML cell lines.

“I am honored and grateful to be supported by CURE Childhood Cancer and the Sam Robb Fund. I am inspired by their mission to conquer childhood cancer and to support patients and their families. As a physician I witness every day the impact CURE has on my patients and their families and I hope, through my research supported by CURE, to further gain knowledge about how different types of cancer respond to treatment and contribute to developing targeted therapies for childhood cancer.”

Dr. Sanyu Janardan

Connolly Family Fellow

Dr. Janardan earned her MD at the University of Minnesota and completed her pediatrics residency at Yale. Dr. Janardan’s fellowship research will focus on studying barriers to exercise in childhood cancer survivors and she will be completing her Masters of Science in Clinical Research at Emory University during her fellowship.

“I am so grateful to have funding from CURE as this will allow me to focus my time and energy during fellowship toward my research endeavors and patient care. The opportunity to work with this organization to help support our patients and families means so much to me.”

Dr. Sanyu Janardan

Connolly Family Fellow

Dr. Janardan earned her MD at the University of Minnesota and completed her pediatrics residency at Yale. Dr. Janardan’s fellowship research will focus on studying barriers to exercise in childhood cancer survivors and she will be completing her Masters of Science in Clinical Research at Emory University during her fellowship.

“I am so grateful to have funding from CURE as this will allow me to focus my time and energy during fellowship toward my research endeavors and patient care. The opportunity to work with this organization to help support our patients and families means so much to me.”

Past Fellows

Through the generous support of our donors, CURE Childhood Cancer has funded 21 research fellowships in the effort to fight pediatric cancer. Eighteen past CURE Fellows are now practicing medicine in top institutions around the country, treating patients and pursuing research for cures. Roll over an image below to see where they are now.

Becker Hewes, MD

Chief Medical Officer, Torque Therapeutics

Roland Chu, MD

Pediatric Hematologist/Oncologist, Children’s Hospital of Michigan

Karen Wasilewski, MD

Pediatric Hematologist/Oncologist, Children’s Healthcare of Atlanta

Mary Abraham, MD

Associate Director, Rheumatology Fellowship Program, NYU Langone Health

Hal Crosswell, MD

Pediatric Hematologist/Oncologist, St. Francis Cancer Center, Greenville, SC

Keith August, MD, MS

Pediatric Hematologist/Oncologist, Director, Leukemia and Lymphoma Program, Children’s Mercy Hospital, Kansas City

Tanya Watt, MD

Assistant Professor, University of Texas Southwestern / Pediatric Hematologist/Oncologist, Children’s Health, Dallas

Weston Miller, MD

Assistant Professor, Division of Pediatric Blood and Marrow Transplantation, University of Minnesota  Medical Center

Nicole Schlesinger McKinney, MD

Pediatric Hematologist/Oncologist, Memorial Hospital, Aurora, CO

Himalee Sabnis, MD, MSc

Pediatric Hematologist/Oncologist, Children’s Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine

Jennifer Andrews, MD, MSc

Assistant Professor of Pathology, Microbiology & Immunology and Pediatrics at Vanderbilt University Medical Center

Haneen Yasin Abdella, MD

Pediatric Hematologist/Oncologist, Nicklaus Children’s Hospital, Miami, FL

Ryan Summers, MD

Pediatric Hematology/Oncology, Children’s Healthcare of Atlanta

 

Jonathan Metts, MD

Pediatric Hematologist/Oncologist, Johns Hopkins All-Children’s, St. Petersburg, FL

David Siegel, MD, MPH

Medical Officer, Commissioned Corps of the US Public Health Service/CDC

Jim Felker, MD

Assistant Professor, Pediatric Neuro-Oncology Program, Children’s Hospital of Pittsburgh, PA

Jenny Shim, MD

Senior Research Associate, Pediatric Hematology/Oncology, Children’s Healthcare of Atlanta

Rafi Kazi, MD

Senior Research Associate, Pediatric Hematology/Oncology, Children’s Healthcare of Atlanta